Prevalence of Uncontrolled Hypertension in Patients With Fabry Disease
Author(s) -
Julia Kleinert,
F. Dehout,
Andreas Schwarting,
Antonino De Lorenzo,
Riccardo Ricci,
Christoph Kampmann,
M BECK,
Uma Ramaswami,
Aleš Linhart,
Andreas Gal
Publication year - 2006
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2006.01.011
Subject(s) - medicine , fabry disease , blood pressure , enzyme replacement therapy , kidney disease , cardiology , diastole , gastroenterology , disease
Fabry disease is a rare X-linked disease arising from deficiency of alpha-galactosidase A. It results in early death related to renal, cardiac, and cerebrovascular disease, which are also important outcomes in patients with elevated blood pressure (BP). The prevalence of uncontrolled hypertension, as well as the effect of enzyme replacement therapy on BP, in patients with Fabry disease is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom